New Approaches and Recommendations for Risk‐Adapted Breast Cancer Screening
Journal of Magnetic Resonance Imaging · 2023-10 · 58 (4) · 987-1010
DOI: 10.1002/jmri.28731 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 11.04.2023. Verfasst von Marialena I Tsarouchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Population‐based breast cancer screening using mammography as the gold standard imaging modality has been in clinical practice for over 40 years. However, the limitations of mammography in terms of sensitivity and high false‐positive rates, particularly in high‐risk women, challenge the indiscriminate nature of population‐based screening. Additionally, in light of expanding research on new breast cancer risk factors, there is a growing consensus that breast cancer screening should move toward a risk‐adapted approach. Recent advancements in breast imaging technology, including contrast material‐enhanced mammography (CEM), ultrasound (US) (automated‐breast US, Doppler, elastography US), and especially magnetic resonance imaging (MRI) (abbreviated, ultrafast, and contrast‐agent free), may provide new opportunities for risk‐adapted personalized screening strategies. Moreover, the integration of artificial intelligence and radiomics techniques has the potential to enhance the performance of risk‐adapted screening. This review article summarizes the current evidence and challenges in breast cancer screening and highlights potential future perspectives for various imaging techniques in a risk‐adapted breast cancer screening approach. Evidence Level 1. Technical Efficacy Stage 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Radiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID-Profile: Marialena I Tsarouchi, Alma Hoxhaj, Ritse M Mann
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Tsarouchi, M. I., Hoxhaj, A., & Mann, R. M. (2023). New Approaches and Recommendations for Risk‐Adapted Breast Cancer Screening. Journal of Magnetic Resonance Imaging, 58(4), 987-1010. https://doi.org/10.1002/jmri.28731
Vancouver
Tsarouchi MI, Hoxhaj A, Mann RM. New Approaches and Recommendations for Risk‐Adapted Breast Cancer Screening. Journal of Magnetic Resonance Imaging. 2023;58(4):987-1010. doi:10.1002/jmri.28731
BibTeX
@article{Tsarouchi2023,
author = {Tsarouchi, Marialena I and Hoxhaj, Alma and Mann, Ritse M},
title = {New Approaches and Recommendations for Risk‐Adapted Breast Cancer Screening},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
volume = {58},
number = {4},
pages = {987--1010},
doi = {10.1002/jmri.28731}
}
EUVIMED